Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 5Completed 5Not yet recruiting 3Active not recruiting 3Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 4Thoracic 3Breast 3Sarcoma 2Gynecologic 2Other neoplasm 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Head & Neck 1Endocrine 1

Conditions

Oropharyngeal Neoplasms 1Mouth Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 57pembrolizumab 54Cetuximab 43Radiotherapy 35Docetaxel 21Radiotherapy, Intensity-Modulated 20Paclitaxel 19Nivolumab 18Fluorouracil 18Carboplatin 17Radiation 14Radiosurgery 9Magnetic Resonance Spectroscopy 8Gemcitabine 8Everolimus 8Biopsy 8Surgical Procedures, Operative 7Oxaliplatin 7Cyclophosphamide 7durvalumab 6avelumab 6Erlotinib Hydrochloride 6Capecitabine 6spartalizumab 5epacadostat 5Surveys and Questionnaires 5Platinum 5Immunoglobulin G 5Gefitinib 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Observation × Head & Neck × Clear all
NCT00537199 2016-05-13

OraTest in Combination With Visual Examination and Visual Examination Alone

M.D. Anderson Cancer Center

Phase 3 Terminated
1 enrolled 2 charts
Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡